M&A Deal Summary

Natus Acquires Integra LifeSciences Holdings - Neurosurgery Assets

On September 11, 2017, Natus acquired medical products company Integra LifeSciences Holdings - Neurosurgery Assets from Integra LifeSciences Holdings for 48M USD

Acquisition Highlights
  • This is Natus’ 9th transaction in the Medical Products sector.
  • This is Natus’ 4th largest (disclosed) transaction.
  • This is Natus’ 8th transaction in the United States.
  • This is Natus’ 1st transaction in New Jersey.

M&A Deal Summary

Date 2017-09-11
Target Integra LifeSciences Holdings - Neurosurgery Assets
Sector Medical Products
Buyer(s) Natus
Sellers(s) Integra LifeSciences Holdings
Deal Type Divestiture
Deal Value 48M USD

Target

Integra LifeSciences Holdings - Neurosurgery Assets

Plainsboro, New Jersey, United States
Integra LifeSciences Holdings Corp. - Neurosurgery Assets is a provider of medical products in New Jersey.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Natus

Middleton, Wisconsin, United States

Category Company
Founded 1987
Sector Medical Products
Revenue 473M USD (2021)
DESCRIPTION

Natus is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Natus was founded in 1987 and is based in Pleasanton, California.


DEAL STATS #
Overall 10 of 12
Sector (Medical Products) 9 of 11
Type (Divestiture) 3 of 3
State (New Jersey) 1 of 1
Country (United States) 8 of 8
Year (2017) 1 of 1
Size (of disclosed) 4 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-09-26 GN Otometrics

Ballerup, Denmark

GN Otometrics is a manufacturer of hearing diagnostics and balance assessment equipment, disposables & software, currently being sold in over 86 countries.

Buy $145M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-02 Medix Medical Devices SRL

Buenos Aires, Argentina

Medix Medical Devices SRL designs and markets state-of-the-art technology to take care of the needs of newborns, assuming a commitment to improving the quality of life from the start.

Sell -

Seller(S) 1

SELLER

Integra LifeSciences Holdings

Princeton, New Jersey, United States

Category Company
Founded 1989
Sector Medical Products
Employees3,946
Revenue 1.5B USD (2023)
DESCRIPTION

Integra LifeSciences Holdings is a major medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra LifeSciences Holdings was founded in 1989 and is based in Princeton, New Jersey.


DEAL STATS #
Overall 2 of 3
Sector (Medical Products) 2 of 3
Type (Divestiture) 1 of 2
State (New Jersey) 1 of 2
Country (United States) 2 of 3
Year (2017) 1 of 1
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-02-15 Johnson & Johnson - Codman Neurosurgery Business

Raynham, Massachusetts, United States

Johnson & Johnson - Codman Neurosurgery Business is a global neurosurgery and neurovascular company that offers a broad portfolio of devices for hydrocephalus management, neuro intensive care and cranial surgery, as well as aneurysm coils, vascular reconstruction devices and other technologies used in the endovascular treatment of cerebral aneurysms and stroke.

Buy $1.0B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-09-29 Integra LifeSciences Holdings - Extremity Orthopaedics Business

Princeton, New Jersey, United States

Integra LifeSciences Holdings Corp. - Extremity Orthopaedics Business includes shoulder replacement and upper and lower extremities portfolio, and an exciting new product pipeline. The focused extremities commercial channel includes a specialized sales force and distributors, predominantly in the US as well as Canada and Europe.

Sell $240M